Onco创新和Nucro-Technics伙伴将癌症治疗推向人类试验。 Onco-Innovations and Nucro-Technics partner to advance cancer treatment toward human trials.

Onco-Involutions公司与Nucro-Technics公司签订了一项协议,开展IND-授权研究,标志着在开始对人类进行新治疗试验方面迈出了重要一步。 Onco-Innovations has entered into an agreement with Nucro-Technics to conduct IND-enabling studies, marking a significant step towards beginning human trials for their new treatment. 这一协作旨在收集必要的数据,以便向林业发展局提交一份调查性新药物(IND)申请,推动其癌症治疗更接近患者使用。 This collaboration aims to gather necessary data to submit an Investigational New Drug (IND) application to the FDA, advancing their cancer therapy closer to patient use.